A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 375-379

  Lu, Huimei ^a   Kyo, Eikai ^b   Uesaka, Toshihiro ^a   Katoh, Osamu ^a   Watanabe, Hiromitsu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

AOM; Chemoprevention; Colon cancer; Rat; catenin

Indexed keywords

ANTINEOPLASTIC AGENT; AZOXYMETHANE; CYCLINE; PLANT EXTRACT; TUMOR MARKER;

ADENOMA; ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CHEMICALLY INDUCED DISORDER; COLON TUMOR; CULTURE MEDIUM; DRUG EFFECT; ENZYME IMMUNOASSAY; FISCHER 344 RAT; GANODERMA LUCIDUM; MALE; METABOLISM; MYCELIUM; PATHOLOGY; RAT;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CELL DIVISION; COLONIC NEOPLASMS; CULTURE MEDIA; IMMUNOENZYME TECHNIQUES; MALE; MYCELIUM; PLANT EXTRACTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; REISHI; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0038148425     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.375     Document Type: Article

References (33)

1. Shiao MS, Lee KR, Lin LJ and Wang CT: Natural products and biological activities of Chinese medical fungus, Ganoderma lucidum. Food phytochemicals for cancer prevention. II. Teas, spices and herbs. Ho CT, Osawa T, Haung MT and Rosen RT (eds). American Chemical Society, Washington, DC, pp342-354, 1994.
2. Franz G: Polysaccharides in pharmacy: current applications and future concepts. Planta Med 55: 493-497, 1989.
3. Furusawa E, Chon SC, Furusawa S, Hirazami A and Dang Y: Anti-tumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synegeneic mice. Phytother Res 6: 300-304, 1992.
4. Maruyama H, Yamazaki K, Murofushi S, Konda C and Ikekawa T: Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobiodyn 12: 118-123, 1989. (Pubitemid 19083850)
5. Yun T: Update from Asia. Asian studies on cancer chemoprevention. Ann NY Acad Sci 88: 157-192, 1999.
6. Miyazaki T and Nishijima M: Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29: 3611-3616, 1981. (Pubitemid 12154632)
7. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS and Ho CK: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70: 699-705, 1997. (Pubitemid 27158450)
8. Hikino H, Konno C, Mirin Y and Hayashi T: Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med 51: 339-340, 1985.
9. Tomoda M, Gonda R, Katahara Y and Hikino H: Glycan structures of Ganoderma lucidum fruit bodies. Phyochem 25: 2817-2874, 1986.
10. Bao X, Liu C, Fang I and Li X: Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res 332: 67-74, 2001. (Pubitemid 32441606)
11. Bao XF, Wang XS, Dong Q, Fang JN and Li XY: Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59: 175-181, 2002. (Pubitemid 34123582)
12. Lin JM, Lin CC, Chen MF, Ujiie T and Takada A: Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neojaponicum. J Ethnopharmacol 47: 33-41, 1995.
13. Zhu HS, Yang XL, Wang LB, Zhao DX and Chen L: Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16: 201-206, 2000.
14. Lieu CW, Lee SS and Wang SY: The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12: 1211-1215, 1992.
15. Tao J and Feng KY: Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongji Med Univ 10: 240-243, 1990.
16. Eo SK, Kim YS, Lee CK and Han SS: Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol 72: 475-481, 2000.
17. Zhang LX, Mong H and Zhou XB: Effect of Japanese Ganoderma lucidum on production of interleukin-2 from murine splenocytes. Zhongguo Zhong Xi Yi Jie He Za Zhi (In Chinese) 13 :613-615, 1993.
18. Lu H, Uesaka T, Katoh O, Kyo E and Watanabe H: Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep 8: 1341-1345, 2001. (Pubitemid 33758743)
19. Lu H, Kyo E, Uesaka T, Katoh O and Watanabe H: Prevention of development of N,N′-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med 9: 113-117, 2002.
20. Masaoka Y, Watanabe H, Katoh O, Ito A and Dohi K: Effects of miso and NaCl on the development of colonic aberrant crypt foci induced by azozymethane in F344 rats. Nutr Cancer 32: 25-28, 1998. (Pubitemid 28519239)
21. Magnuson BA, Carr I and Bird RP: Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 53: 4499-4504, 1993. (Pubitemid 23304371)
22. Kumemura M, Shimizu S, Tanizaki M, et al: The early phase of colon tumorigenesis induced by dimethylhydrazine in ICR mice. Oncol Rep 5: 621-624, 1998. (Pubitemid 28189315)
23. Komatsu S, Watanabe H, Oka T, Tsuge H, Nii H and Kato N: Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131: 2204-2207, 2001. (Pubitemid 32720653)
24. Sasaki M, Kato N, Watanabe H and Yamada H: Silk protein, sericin, suppresses colon carcinogenesis induced by 1,2-dimethylhydrazine in mice. Oncol Rep 7: 1049-1052, 2000.
25. Zhaorigetu S, Sasak M, Watanabe H and Kato N: Supplement silk protein, sericin, suppresses colon tumorigenesis in 1,2-dimethylhydrazine-treated mice by reducing oxidative stress and cell proliferation. Biosci Biotechnol Biochem 65: 2181-2186, 2001. (Pubitemid 33617187)
26. Yang K, Lamprecht SA, Liu Y, et al: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21: 1655-1660, 2000.
27. Liu Z, Uesaka T, Watanabe H and Kato N: High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 19: 1009-1014, 2001.
28. Bao X, Duan J, Fang X and Fang J: Chemical modifications of the (1→3)-α-D-glucan from spores of Ganoderma lucidum and investigation of their physicochemical properties and immunological activity. Carbohydr Res 336: 127-140, 2001. (Pubitemid 33016566)
29. Takahashi M, Nakatsugi S, Sugimura T and Wakabayashi K: Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21: 1117-1120, 2000. (Pubitemid 30389335)
30. Takahashi M, Fukuda K, Sugimura T and Wakabayashi K: β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58: 42-46, 1998. (Pubitemid 28027714)
31. Yamada Y, Yoshimi N, Hirose Y, et al: Sequential analysis of morphological and biological properties of β-catenin-aecumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 61: 1874-1878, 2001. (Pubitemid 32692002)
32. Herter P, Kühnen C, Müller KM, Wittinghofer A and Müller O: Intracellular distribution of β-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. J Cancer Res Clin Oncol 125: 297-304, 1999. (Pubitemid 29243102)
33. Brabletz T, Jung A, Hermann K, Günther K, Hohenberger W and Kirchner T: Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704, 1998. (Pubitemid 28523944)